BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lv T, Chen S, Li M, Zhang D, Kong Y, Jia J. Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta-analysis. J Gastroenterol Hepatol 2021;36:1423-34. [PMID: 33141955 DOI: 10.1111/jgh.15329] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Kimura M, Ogawa E, Harada K, Imamura J, Saio M, Ikura Y, Yatsuhashi H, Murata K, Miura K, Ieiri I, Tanaka A, Kimura K. Feasibility, safety and tolerability of the CREB-binding protein/β-catenin inhibitor OP-724 in patients with advanced primary biliary cholangitis: an investigator-initiated, open-label, non-randomised, two-centre, phase 1 study. BMJ Open Gastroenterol 2022;9:e001001. [DOI: 10.1136/bmjgast-2022-001001] [Reference Citation Analysis]
2 Floreani A, Gabbia D, De Martin S. Obeticholic Acid for Primary Biliary Cholangitis. Biomedicines 2022;10:2464. [PMID: 36289726 DOI: 10.3390/biomedicines10102464] [Reference Citation Analysis]
3 Shen ZX, Wu DD, Xia J, Wang XB, Zheng X, Huang Y, Li BL, Meng ZJ, Gao YH, Qian ZP, Liu F, Lu XB, Shang J, Yan HD, Zheng YB, Gu WY, Zhang Y, Wei JY, Tan WT, Hou YX, Zhang Q, Xiong Y, Zou CC, Chen J, Huang ZB, Jiang XH, Luo S, Chen YY, Gao N, Liu CY, Yuan W, Mei X, Li J, Li T, Zhou XY, Deng GH, Chen JJ, Ma X, Li H. Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China. World J Gastroenterol 2022; 28(31): 4417-4430 [DOI: 10.3748/wjg.v28.i31.4417] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Floreani A, Gabbia D, De Martin S. Update on the Pharmacological Treatment of Primary Biliary Cholangitis. Biomedicines 2022;10:2033. [DOI: 10.3390/biomedicines10082033] [Reference Citation Analysis]
5 Ayala-sierra EF, Muñoz-maya O, Guerrero-pérez F, Cardona-jaramillo M. Colangitis biliar primaria: caracterización de una cohorte retrospectiva. Hepatología 2022. [DOI: 10.52784/27112330.159] [Reference Citation Analysis]
6 Zhang Y, Jiao Z, Chen M, Shen B, Shuai Z. Roles of Non-Coding RNAs in Primary Biliary Cholangitis. Front Mol Biosci 2022;9:915993. [DOI: 10.3389/fmolb.2022.915993] [Reference Citation Analysis]
7 Wang ZL, Song KM, Jin R, Xie YD, Wang YQ, Liu ZC, Feng B. Combination therapy of ursodeoxycholic acid and glucocorticoid and (or) immunosuppressant in patients with primary biliary cholangitis: A meta-analysis. Medicine (Baltimore) 2022;101:e28987. [PMID: 35244071 DOI: 10.1097/MD.0000000000028987] [Reference Citation Analysis]
8 You H, Ma X, Efe C, Wang G, Jeong SH, Abe K, Duan W, Chen S, Kong Y, Zhang D, Wei L, Wang FS, Lin HC, Yang JM, Tanwandee T, Gani RA, Payawal DA, Sharma BC, Hou J, Yokosuka O, Dokmeci AK, Crawford D, Kao JH, Piratvisuth T, Suh DJ, Lesmana LA, Sollano J, Lau G, Sarin SK, Omata M, Tanaka A, Jia J. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis. Hepatol Int 2022. [PMID: 35119627 DOI: 10.1007/s12072-021-10276-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut 2021;70:1989-2003. [PMID: 34266966 DOI: 10.1136/gutjnl-2020-322362] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 24.0] [Reference Citation Analysis]
10 Gazda J, Drazilova S, Janicko M, Jarcuska P. The Epidemiology of Primary Biliary Cholangitis in European Countries: A Systematic Review and Meta-Analysis. Can J Gastroenterol Hepatol 2021;2021:9151525. [PMID: 34239845 DOI: 10.1155/2021/9151525] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 French J, Simpson-Yap S, van der Mei I, Ng J, Angus P, Gow PJ. Identification of a Latitude Gradient in the Prevalence of Primary Biliary Cholangitis. Clin Transl Gastroenterol 2021;12:e00357. [PMID: 34003806 DOI: 10.14309/ctg.0000000000000357] [Reference Citation Analysis]